Results 141 to 150 of about 16,679 (224)

Nintedanib in progressive bronchiolitis obliterans syndrome (BOS) grade 0p-1-2 in lung transplant recipients (INFINITIx-BOS): protocol of a French multicenter randomized controlled trial. [PDF]

open access: yesTrials
Brugière O   +10 more
europepmc   +1 more source

Salvage nintedanib plus low-dose ruxolitinib therapy for bronchiolitis obliterans syndrome refractory to calcineurin inhibitors and glucocorticoids after allogeneic transplantation. [PDF]

open access: yesCell Transplant
Luo Y   +15 more
europepmc   +1 more source

Identification of Surrogate Outcome Biomarkers in Lung Allograft Recipients With Bronchiolitis Obliterans: Implications for Randomized Controlled Trials. [PDF]

open access: yesTransplant Direct
Byers DE   +35 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy